Panelists John Marshall, MD; Johanna Bendell, MD; Tanios Bekaii-Saab, MD; and Alan P. Venook, MD, debate the pros and cons of employing a neoadjuvant strategy in metastatic colorectal cancer, the use of various imaging techniques to detect liver lesions, and the role of adjuvant therapies.